Page 156 - 79_01

J.
R.
Lacadena
y
F.
Mayor
Menéndez

28.
Kobilka,
B.
K.;
Kobilka,
T.
S.
et
al.
Chimeric
alpha
2-­-,beta
2-­-adrenergic
receptors:
delineation

of
domains
involved
in
effector
coupling
and
ligand
binding
specificity.
Science
240,
1310-­-
1316
(1988).

29.
Pitcher,
J.A;

Freedman,
N.J.;

Lefkowitz,
R.J.
G
protein-­-coupled
receptor
kinases.
Annu
Rev

Biochem
67,
653-­-792
(1998).

30.
Lefkowitz
,R.J.;

Shenoy,
S.K.
Transduction
of
receptor
signals
by
beta-­-arrestins.
Science

308,
512-­-517
(2005)

31.
Rasmussen,
S.
G.;

Choi,
H.
J.
et
al.
Crystal
structure
of
the
human
beta2
adrenergic
G-­-
protein-­-coupled
receptor.
Nature
450,
383-­-387
(2007).

32.
Cherezov,
V.;
Rosenbaum,
D.
M.

et
al.
High-­-resolution
crystal
structure
of
an
engineered

human
beta2-­-adrenergic
G
protein-­-coupled
receptor.
Science
318,
1258-­-1265
(2007).

33.
Rosenbaum,
D.
M.;

Cherezov,
V.
et
al.
GPCR
engineering
yields
high-­-resolution
structural

insights
into
beta2-­-adrenergic
receptor
function.
Science
318,
1266-­-1273
(2007).

34.
Palczewski,
K.;

Kumasaka,
T.
et
al.

Crystal
structure
of
rhodopsin:
A
G
protein-­-coupled

receptor.
Science
289,
739-­-745
(2000).

35.
Okada,
T.;

Fujiyoshi,
Y.
et
al.
Functional
role
of
internal
water
molecules
in
rhodopsin

revealed
by
X-­-ray
crystallography.
Proc
Natl
Acad
Sci
USA
99,

5982-­-5987.
(2002).

36.
Katritch,
V.;
Cherezov,
V.
et
al.
Structure-­-function
of
the
g
protein-­-coupled
receptor

superfamily.

Annu
Rev
Pharmacol
Toxicol
53,
531-­-556
(2013).

37.
Katritch,
V.;
Cherezov,
V.
et
al.
Diversity
and
modularity
of
G
protein-­-coupled
receptor

structures.
Trends
Pharmacol
Sci
33,

17-­-27
(2012).

38.
Rasmussen,
S.G.;
DeVree,
B.T.
et
al.
Crystal
structure
of
the
beta2
adrenergic
receptor-­-Gs

protein
complex.
Nature
477,
549-­-555
(2011).

39.
Chung,
K.
Y.;
Rasmussen,
S.
G.
et
al.
Conformational
changes
in
the
G
protein
Gs
induced
by

the
beta2
adrenergic
receptor.
Nature
477,
611-­-615
(2011).

40.
Penela,
P.,
Murga,
C.
et
al.
The
complex
G
protein-­-coupled
receptor
kinase
2
(GRK2)

interactome
unveils
new
physiopathological
targets.
Br
J
Pharmacol
160,
821-­-832
(2010).

150